Among those who discontinued, 47.3% of patients with type 2 diabetes and 36.3% of those without reinitiated therapy within a year
Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review
Can Wegovy (semaglutide) cause dizziness?
The Sentinel HRA helps fill this gap by allowing employers to provide access to GLP-1 medications with defined cost controls, including annual reimbursement limits and specific eligibility criteria
This means licensed pharmacies can once again legally compound BPC-157 for tissue repair, gut health, and musculoskeletal support under medical supervision
They do not replace arthritis medications like DMARDs or biologics, but can be used, with caution, in conjunction with them, only under medical supervision